ENDRA Life Sciences (NDRA) Change in Accured Expenses (2016 - 2026)
ENDRA Life Sciences (NDRA) reported Change in Accured Expenses of $79908.0 for Q1 2026, up 216.48% year-over-year from $25249.2 in Q1 2025, and up 260.02% quarter-over-quarter from -$49937.0 in Q4 2025.
ENDRA Life Sciences (NDRA) Change in Accured Expenses (2016 - 2026) Analysis & Trends
ENDRA Life Sciences (NDRA) has 11 years of Change in Accured Expenses data on file, last reported at $79908.0 in Q1 2026.
- Change in Accured Expenses for Q1 2026 came in at $79908.0, up 216.48% year-over-year; the trailing twelve-month figure through Mar 2026 was $261799.0 (up 143.26% YoY), and the FY2025 annual result was $113287.0, up 156.97% from the prior year.
- Change in Accured Expenses grew to $79908.0 in Q1 2026 per NDRA's latest filing, from -$49937.0 in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $337711.0 in Q1 2024 and troughed at -$1.3 million in Q4 2023.
- A 5-year average of -$42138.5 and a median of $79908.0 in 2026 frame the typical range for Change in Accured Expenses.
- The sharpest annual moves came in 2022 and 2023: Change in Accured Expenses surged 400.8% in 2022, then tumbled 3524.36% in 2023.
- A 5-year view of Change in Accured Expenses shows it stood at -$35085.0 in 2022, then plunged by 3524.36% to -$1.3 million in 2023, then jumped by 90.19% to -$124769.0 in 2024, then surged by 59.98% to -$49937.0 in 2025, then surged by 260.02% to $79908.0 in 2026.
- Business Quant data shows NDRA's Change in Accured Expenses at $79908.0 in Q1 2026, -$49937.0 in Q4 2025, and $223095.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,149.49 Bn | 29,149.03 Bn | 1.11 Bn | 235.00 Mn |
| 2 | Thermo Fisher Scientific | 174.37 Bn | 171.12 Bn | 7.74 Bn | - |
| 3 | Danaher | 127.33 Bn | 121.64 Bn | 3.59 Bn | -322.00 Mn |
| 4 | Idexx Laboratories | 44.68 Bn | 44.48 Bn | 722.74 Mn | - |
| 5 | Agilent Technologies | 36.54 Bn | 34.74 Bn | 990.00 Mn | - |
| 6 | Iqvia Holdings | 30.51 Bn | 28.53 Bn | 1.36 Bn | - |
| 7 | Natera | 30.00 Bn | 28.90 Bn | 696.04 Mn | 98.23 Mn |
| 8 | Illumina | 24.61 Bn | 23.45 Bn | 721.00 Mn | -47.00 Mn |
| 9 | Mettler Toledo International | 22.91 Bn | 22.85 Bn | 555.82 Mn | - |
| 10 | ENDRA Life Sciences | 5.52 Mn | 5.16 Mn | - | 79,908.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 79,908.00 |
| Mar 31, 2026 | 79,908.00 |
| Dec 31, 2025 | -49,937.00 |
| Dec 31, 2025 | -49,937.00 |
| Sep 30, 2025 | 223,095.00 |
| Sep 30, 2025 | 223,095.00 |
| Jun 30, 2025 | 8,733.00 |
| Jun 30, 2025 | 8,733.00 |
| Mar 31, 2025 | -68,604.00 |
| Mar 31, 2025 | -68,604.00 |
| Dec 31, 2024 | -124,769.00 |
| Dec 31, 2024 | -124,769.00 |
| Sep 30, 2024 | -540,778.00 |
| Sep 30, 2024 | -540,778.00 |
| Jun 30, 2024 | 128,969.00 |
| Jun 30, 2024 | 128,969.00 |
| Mar 31, 2024 | 337,711.00 |
| Mar 31, 2024 | 337,711.00 |
| Dec 31, 2023 | -1.27 Mn |
| Dec 31, 2023 | -1.27 Mn |